Screening drugs in saliva
Scientists from Stockholm University in Sweden have developed a method for screening and determining drugs in human saliva using microextraction by packed sorbent (MEPS) and liquid chromatography tandem mass spectrometry (LC?MS?MS).1
Scientists from Stockholm University in Sweden have developed a method for screening and determining drugs in human saliva using microextraction by packed sorbent (MEPS) and liquid chromatography tandem mass spectrometry (LC–MS–MS).1
Traditionally, blood, plasma, and urine are used in drug studies in clinical and preclinical settings. Saliva, on the other hand, offers a non-invasive alternative to these traditional options. A range of drugs and their metabolites can be found in different concentrations in saliva. Lead author, Mohamed Abdel-Rehim, told The Column: “I was interested in this area for some years ago since I know many people (one of them is my son) are scared when they give blood samples. I became interested in saliva because saliva offers fast and non-invasive sampling. The collection and storage of saliva is also easier than blood.”
MEPS is a miniaturized sample preparation technique invented by Abdel-Rehim, and has been used to extract a wide range of drugs. In this study, published in Biomedical Chromatography, the team used lidocaine, a common local anesthetic, as the drug they extracted from saliva. A sample of 500 mg lidocaine salve was applied topically to the skin and saliva samples were collected at 0 h, 1 h, 1.5 h, 2 h, 3 h, and 4 h. The samples were then passed through the MEPS sorbent and analysed by LC–MS–MS.
The team was able to collect an exact volume of saliva at each attempt and high throughput was achieved. When the results were compared with those obtained from plasma, they were found to be similar. The only difference was that the concentration levels were lower in saliva than plasma. The method was regarded as cost-effective because the MEPS sorbent could be used more than 50 times before it was disposed of.
It was concluded that the study was suitable for automation and the small sample collections makes it ideal to obtain samples from children. Abdel-Rehim added: “The use of oral fluids as drug testing and as [a] diagnostic tool will be investigated in future work.”
Reference
1. A. Abdel-Rehim and M. Abdel-Rehim, Biomedical Chromatography DOI:10.1002/bmc.2925 (2013).
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
